Labiotech.eu

News and Trends 16 Jan 2018

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

e-Therapeutics has teamed up with AI experts Intellegens and Biorelate to improve its technology for computer-based drug discovery. Based in Oxford, e-Therapeutics has the mission of reducing the time and money it costs to develop new drugs with the help of artificial intelligence. Its platform can explore large amounts of public and private databases to […]

January 16, 2018 - 1 minutemin - By Clara Rodríguez Fernández

da volterra antibiotic resistance trial 1

News and Trends 16 Jan 2018

This French Biotech’s Medical Device Protects Against Antibiotic Resistance

Da Volterra has achieved impressive early results with its antibiotic resistance-busting medical device by successfully protecting the diversity of the microbiome. French biotech Da Volterra is developing products to fight the rapidly rising rates of antibiotic resistance. During a Phase I study, the company’s medical device, DAV132, was used with the antibiotic, moxifloxacin, and successfully protected the intestinal […]

January 16, 2018 - 2 minutesmins - By Alex Dale

News and Trends 16 Jan 2018

Dutch Biotech Joins International Effort to Eradicate Polio

Batavia Biosciences joins an international consortium to develop and manufacture a safer type of polio vaccine. Their ultimate goal is to eradicate the disease. Based in Leiden, the Netherlands, Batavia Biosciences specializes in the development and production of viruses and proteins. Its expertise has attracted an international consortium to recruit Batavia in their effort to […]

January 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Jan 2018

Two Proteins in the Brain Could Protect Against and Repair the Damage Caused by Parkinson’s

Researchers have found two proteins that could be used to treat Parkinson’s disease patients by exerting neuroprotective and regenerative effects. Scientists at the University of the Basque Country have found that two neurotrophic factors work in synergy to benefit patients with early-stage Parkinson’s disease. The findings, based on research carried out across a number of studies, […]

January 16, 2018 - 3 minutesmins - By Alex Dale

News and Trends 16 Jan 2018

Young Oxford Biotech Raises €22.5M to Develop a Universal Flu Vaccine

Vaccitech has closed a Series A fundraising that will support clinical trials with its vaccine technology against influenza and prostate cancer. Spun out from Oxford University in 2016, Vaccitech has now closed its Series A fundraising round. Amounting to a total of £20M (€22.5M), the round was co-led by GV, Oxford Sciences Innovation and Sequoia China, and joined […]

January 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Having developed multispecific antibodies with F-star, Denali Therapeutics has joined forces with Takeda Pharmaceuticals to commercialize Alzheimer’s drugs using the technology. F-star’s bispecific antibody technology has received validation in the form of two pharma companies using it for the development of new drugs for neurodegenerative diseases. San Francisco-based Denali Therapeutics and Japanese company Takeda will collaborate on […]

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 15 Jan 2018

The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead

The UK big pharma company’s Lynparza will be for women with advanced breast cancer that is specifically caused by mutations in the BRCA gene. Global pharma giant AstraZeneca focuses on the development of drugs for cancer, cardiovascular and respiratory diseases. The company, which is working on a number of small molecules and biologics for a […]

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 15 Jan 2018

This is Why You Should Avoid Eating too Much Junk Food

Following last week’s article about the importance of eating plenty of fruit and vegetables, German researchers have unearthed another link between junk food and diabetes and heart disease. Researchers from the University of Bonn, Germany, have found that an unhealthy diet can cause the immune system to act as if it is responding to bacterial […]

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 13 Jan 2018

Mars Astronauts Might Wear Spacesuits Made of Fungi

A team of biodesigners is getting us ready to live on Mars by creating the clothes that future Martians will use using fungi to create the materials. Science fiction has been preparing us for the colonization of Mars for over a century. Many see the planet as an alternative home for when we destroy or overcrowd […]

January 13, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Jan 2018

This Collaboration Will Develop a New Epilepsy Gene Therapy for In-Need Patients

CombiGene and the Cell and Gene Therapy Catapult have struck a deal that will move the biotech’s epilepsy therapy towards the clinic. Swedish biotech CombiGene has combined neuroscience and advances in gene delivery to pioneer and new therapy for epilepsy that has brought down the number of seizures in preclinical studies. The company has joined forces […]

January 12, 2018 - 2 minutesmins - By Alex Dale

News and Trends 12 Jan 2018

These Biomaterials Could Help to Make Stem Cell Therapies a Reality

British researchers have developed biomaterials that better recreate the conditions required for stem cells to grow into desired cell types. Researchers at Imperial College London have used 3D printing to create biological structures that can support tissue regeneration. The study, published in Scientific Reports, outlines how the group used cryogenics – freezing – to create a biomaterial that mimics the […]

January 12, 2018 - 3 minutesmins - By Alex Dale

News and Trends 11 Jan 2018

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

The FDA will allow Immunic Therapeutics to commence a Phase II clinical trial to test its oral investigational drug, IMU-838, for the treatment of ulcerative colitis. Immunic Therapeutics, which closed a €31M Series A last September, specializes in the development of drugs for the treatment of chronic inflammatory diseases. At the moment, the company has two ongoing […]

January 11, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

This French Biotech’s Medical Device Protects Against Antibiotic Resistance

Dutch Biotech Joins International Effort to Eradicate Polio

Two Proteins in the Brain Could Protect Against and Repair the Damage Caused by Parkinson’s

Young Oxford Biotech Raises €22.5M to Develop a Universal Flu Vaccine

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead

This is Why You Should Avoid Eating too Much Junk Food

Mars Astronauts Might Wear Spacesuits Made of Fungi

This Collaboration Will Develop a New Epilepsy Gene Therapy for In-Need Patients

These Biomaterials Could Help to Make Stem Cell Therapies a Reality

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!